81 results
8-K
EX-99.2
RPTX
Repare Therapeutics Inc
7 May 24
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
4:10pm
matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 … than expected, changes in expected or existing competition, changes in the regulatory environment, and unexpected litigation or other disputes
8-K
EX-99.1
RPTX
Repare Therapeutics Inc
7 May 24
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
4:10pm
contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and securities laws in Canada. All … environment; the uncertainties and timing of the regulatory approval process; and unexpected litigation or other disputes. Other factors that may cause
8-K
EX-99.1
RPTX
Repare Therapeutics Inc
28 Feb 24
Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:10am
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and securities laws in Canada. All statements … ; the uncertainties and timing of the regulatory approval process; and unexpected litigation or other disputes. Other factors that may cause the Company’s actual
8-K
EX-99.1
yh2ix uujfrwq
12 Feb 24
Termination of a Material Definitive Agreement
4:48pm
8-K
EX-99.1
37ujfy3z
25 Jan 24
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
2:29pm
8-K
EX-99.1
eubrvj50o2
12 Jan 24
Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones
4:05pm
8-K
EX-99.1
1i96m6ejln
15 Nov 23
Regulation FD Disclosure
7:20am
8-K
EX-99.1
78fjq
9 Nov 23
Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
7:05am
8-K
EX-99.2
mhbtkn2c7mwj1nwgg
13 Oct 23
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
v9pmq
13 Oct 23
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
yz3dvy99rc 68srf
13 Oct 23
Repare Therapeutics Announces Positive Initial Data from Phase 1 MYTHIC Clinical Trial
9:47am
8-K
n845hn
13 Oct 23
Repare Therapeutics Announces Positive Initial Data from Phase 1 MYTHIC Clinical Trial
9:47am
8-K
m8ae9
6 Oct 23
Regulation FD Disclosure
7:56am
8-K
EX-99.1
y9ju9kk7jtwawmdc
9 Aug 23
Repare Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
7wtx4
7 Jun 23
Other Events
4:31pm